Panacell Biotech plans to initiate a program to investigate the use of natural killer (NK) immune cells, exosomes and brown adipose-derived stem cells to treat Long COVID.
https://www.pharmalive.com/wp-content/uploads/2020/04/Origin-Ramps-Up-Production-of-3D-Printed-Test-Swabs-BioSpace-4-14-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-11 10:12:182022-08-11 13:11:52Panacell believes stem cell therapy could be effective against Long COVID
